Search form :
Tools Content :
-
Size
Press releases 2012Press releases are intended to journalists, analysts and investors. ASCO Abstracts Highlight Late-stage Sanofi Oncology PipelineMay 17, 2012 Combined General Shareholder Meeting of May 4, 2012May 04, 2012 Genzyme Announces Regulatory Approvals of Expanded Waterford, Ireland Manufacturing PlantMay 03, 2012 Japan Chooses Sanofi Pasteur for First Enhanced Inactivated Polio VaccineApril 27, 2012 Strong performance in Q1 2012 including Genzyme contributionApril 27, 2012 Significant Improvement in Disability Scores Observed in Multiple Sclerosis Patients Who Received Lemtrada™ (Alemtuzumab) Compared With Rebif® in Phase lll TrialApril 24, 2012 Genzyme Demonstrates Depth of MS Pipeline at AAN with Results from Multiple Sclerosis Phase lll TrialsApril 20, 2012 Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson’s DiseaseApril 19, 2012 Sanofi and Regeneron Announce Regulatory and Clinical Update for Zaltrap® (afliberceptApril 05, 2012 Sanofi and Regeneron Report Phase 2 Data for Potential First-in-Class Lipid-Lowering PCSK9 AntibodyMarch 26, 2012 Sanofi to Acquire Pluromed, Inc., Expanding its Presence in BiosurgeryMarch 16, 2012 Filing of the 2011 U.S. Form 20-F and French “Document de Référence” Containing the Annual Financial ReportMarch 07, 2012 Composition of Sanofi’s Board of DirectorsMarch 05, 2012 Sanofi appoints Jean-Luc Lowinski, Senior Vice President, Asia RegionMarch 02, 2012 Genzyme Begins Shipping Fabrazyme from Newly Approved Framingham Manufacturing PlantMarch 01, 2012 Sanofi and the Institut Pasteur Create Four Prestigious Awards to Support Innovative Biomedical ResearchFebruary 27, 2012 2011 Results Benefit from Genzyme Acquisition. Net Sales and Business EPS up 9.2% in Q4February 08, 2012 Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with ApotexFebruary 08, 2012 Sanofi Commits to Eliminate or Control Five Neglected Tropical DiseasesJanuary 30, 2012 Genzyme Announces FDA Approval of Framingham Manufacturing PlantJanuary 24, 2012 Brazil Introduces Inactivated Polio Vaccine in National Immunization Program with Sanofi Pasteur VaccineJanuary 18, 2012 Genzyme Announces European Approval of Framingham Manufacturing PlantJanuary 18, 2012 Sanofi and Venture Capital Firms, Third Rock Ventures and Greylock Partners, Jointly Launch Warp Drive Bio, a Biotechnology Company Combining Innovative Genomics Technologies for Natural Products Drug DiscoveryJanuary 10, 2012 |
Tools menu:
© Sanofi 2004-2012 - All rights reserved - Update: January 10, 2012
